Fairly Prioritizing Groups for Access to COVID-19 Vaccines
Govind Persad, Monica E. Peek, Ezekiel Emanuel
Abstract
The supply of any successful vaccine for coronavirus disease 2019 (COVID-19) will initially be limited. Who should have access first? The US National Academy of Medicine (NAM) has proposed a framework for COVID-19 vaccine allocation. Others have discussed distributing vaccine among countries. This Viewpoint delineates how ethical values should guide prioritization of a COVID-19 vaccine among populations within the US. The discussion may be relevant to other countries as well.
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MEDLINEFamily medicineVirologyInfectious disease (medical specialty)PathologyOutbreakDiseasePolitical scienceLawHealthcare cost, quality, practicesHealthcare Systems and ChallengesVaccine Coverage and Hesitancy